285 related articles for article (PubMed ID: 31801491)
1. Management of paroxysmal atrial flutter that occurred in an outpatient prior to dental surgery: a case report.
Shimoda H; Takahashi T
BMC Oral Health; 2019 Dec; 19(1):271. PubMed ID: 31801491
[TBL] [Abstract][Full Text] [Related]
2. Intravenous administration of diltiazem in the treatment of supraventricular tachyarrhythmias.
Boudonas G; Lefkos N; Efthymiadis AP; Styliadis IG; Tsapas G
Acta Cardiol; 1995; 50(2):125-34. PubMed ID: 7610735
[TBL] [Abstract][Full Text] [Related]
3. [Effects of diltiazem in supraventricular paroxysmal tachyarrhythmias].
De Rosa F; Feraco E; Venneri N; Boncompagni F; Curia F; Guzzo D; Plastina F
G Ital Cardiol; 1986 Sep; 16(9):776-81. PubMed ID: 3803800
[TBL] [Abstract][Full Text] [Related]
4. Treatment of paroxysmal supraventricular tachycardia and atrial flutter-fibrillation with intravenous verapamil: efficacy and mechanism of action.
Sung RJ; Waxman HL; Elser B; Juma Z
Clin Invest Med; 1980; 3(1-2):41-7. PubMed ID: 7009003
[No Abstract] [Full Text] [Related]
5. Beneficial effect of intravenous diltiazem in the acute management of paroxysmal supraventricular tachyarrhythmias.
Betriu A; Chaitman BR; Bourassa MG; Brévers G; Scholl JM; Bruneau P; Gagné P; Chabot M
Circulation; 1983 Jan; 67(1):88-94. PubMed ID: 6847809
[TBL] [Abstract][Full Text] [Related]
6. [Conversion rate and prevention of recurrence of paroxysmal and sustained atrial fibrillation or atrial flutter with verapamil/quinidine].
Trappe HJ; Pfitzner P
Med Klin (Munich); 1996 Oct; 91(10):617-25. PubMed ID: 9019638
[TBL] [Abstract][Full Text] [Related]
7. [Pharmacology of modern anti-arrhythmia drugs in therapy of supraventricular tachycardia].
Honerjäger P; Schmidt G
Z Gesamte Inn Med; 1993 Sep; 48(9):425-9. PubMed ID: 8212747
[TBL] [Abstract][Full Text] [Related]
8. Emergency management of atrial fibrillation and flutter: intravenous diltiazem versus intravenous digoxin.
Schreck DM; Rivera AR; Tricarico VJ
Ann Emerg Med; 1997 Jan; 29(1):135-40. PubMed ID: 8998092
[TBL] [Abstract][Full Text] [Related]
9. Comparison of intravenous diltiazem and verapamil for the acute treatment of atrial fibrillation and atrial flutter.
Phillips BG; Gandhi AJ; Sanoski CA; Just VL; Bauman JL
Pharmacotherapy; 1997; 17(6):1238-45. PubMed ID: 9399606
[TBL] [Abstract][Full Text] [Related]
10. Control of heart rate during transition from intravenous to oral diltiazem in atrial fibrillation or flutter.
Blackshear JL; Stambler BS; Strauss WE; Roy D; Dias VC; Beach CL; Ebener MK
Am J Cardiol; 1996 Dec; 78(11):1246-50. PubMed ID: 8960583
[TBL] [Abstract][Full Text] [Related]
11. Electrocardiographic and electrophysiological characteristics of atrial fibrillation organized into atrial flutter by oral administration of class I antiarrhythmic agents.
Ohmura K; Kobayashi Y; Miyauchi Y; Endoh Y; Atarashi H; Katoh T; Takano T
Pacing Clin Electrophysiol; 2003 Mar; 26(3):692-702. PubMed ID: 12698669
[TBL] [Abstract][Full Text] [Related]
12. Improving Appropriate Dosing of Intravenous dilTIAZem in Patients With Atrial Fibrillation or Flutter With Rapid Ventricular Response in the Emergency Department.
Pon G; Pelsue B; Gulbis B
J Emerg Nurs; 2020 Mar; 46(2):246-253. PubMed ID: 31839326
[TBL] [Abstract][Full Text] [Related]
13. Failure of diltiazem to prevent 1:1 conduction of atrial flutter: a case report.
Tiver KD; Martin DK; Quah J; Lahiri A; Ganesan AN
J Med Case Rep; 2023 Jul; 17(1):319. PubMed ID: 37464369
[TBL] [Abstract][Full Text] [Related]
14. Intravenous flecainide acetate for the clinical management of paroxysmal tachycardias.
Nathan AW; Camm AJ; Bexton RS; Hellestrand KJ
Clin Cardiol; 1987 May; 10(5):317-22. PubMed ID: 3109795
[TBL] [Abstract][Full Text] [Related]
15. Verapamil for control of ventricular rate in paroxysmal supraventricular tachycardia and atrial fibrillation or flutter: a double-blind randomized cross-over study.
Waxman HL; Myerburg RJ; Appel R; Sung RJ
Ann Intern Med; 1981 Jan; 94(1):1-6. PubMed ID: 7447203
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of intravenous diltiazem in atrial fibrillation or atrial flutter.
Ellenbogen KA; Dias VC; Cardello FP; Strauss WE; Simonton CA; Pollak SJ; Wood MA; Stambler BS
Am J Cardiol; 1995 Jan; 75(1):45-9. PubMed ID: 7801862
[TBL] [Abstract][Full Text] [Related]
17. [Medicamentous prevention of symptomatic paroxysmal atrial fibrillation/flutter onset. Goals and design of the SOPAT Study. Executive committee of the investigators representing trial physicians].
Patten M; Koch HP; Sonntag F; Lüderitz B; Meinertz T
Z Kardiol; 1999 Mar; 88(3):185-94. PubMed ID: 10355069
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of paroxysmal supraventricular tachycardia and tachyarrhythmia with verapamil].
Penkov N; Penev A; Kaponov Kh
Vutr Boles; 1984; 23(1):63-9. PubMed ID: 6730453
[TBL] [Abstract][Full Text] [Related]
19. [The treatment of paroxysmal supraventricular arrhythmias in IHD patients with a high risk of developing complications from the anti-arrhythmic therapy].
Andriushchenko OM; Olesin AI
Ter Arkh; 1996; 68(5):57-60. PubMed ID: 9082603
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of invasive and non-invasive electrophysiologic studies in the selection of antiarrhythmic drugs for the patients with paroxysmal supraventricular tachyarrhythmia.
Satake S; Hiejima K; Moroi Y; Hirao K; Kubo I; Suzuki F; Suzuki F
Jpn Circ J; 1985 Mar; 49(3):345-50. PubMed ID: 3981793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
